Moreover, even if CBF-AML are classified as favorable prognosis AML, relapses after intensive chemotherapy remain a major cause of death[26], and a significant proportion of patients (elderly, patients with poor performance status) may not handle intensive chemotherapy toxicities. Here, CEBPZ is linked to acute myeloid leukemia.